Gilad Ofek
University of Maryland, Baltimore
H-index: 27
North America-United States
Top articles of Gilad Ofek
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Prefusion rsv f proteins and their use | 2024/1/18 | ||
HIV-1 neutralizing antibodies and uses thereof | 2024/4/2 | ||
Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development | Brian G Pierce Nathaniel Felbinger Mathew Metcalf Eric A Toth Gilad Ofek | 2024/3/25 | |
Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies | Nature Communications | Matthew C Metcalf Benjamin M Janus Rui Yin Ruixue Wang Johnathan D Guest | 2023/7/5 |
Vaccine Induction of Heterologous HIV-1 Neutralizing Antibody B Cell Lineages in Humans | medRxiv | Wilton B Williams S Munir Alam Gilad Ofek Nathaniel Erdmann David Montefiori | 2023/3/14 |
Cross-reactive macaque antibodies targeting marburgvirus glycoprotein induced by multivalent immunization | bioRxiv | Benjamin M Janus Ruixue Wang Thomas E Cleveland Matthew C Metcalf Aaron C Lemmer | 2023 |
Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge | Journal of Functional Biomaterials | Andrey Romanyuk Ruixue Wang Alexander Marin Benjamin M Janus Eric I Felner | 2022/12/27 |
Structural features of antibody-peptide recognition | Frontiers in Immunology | Jessica H Lee Rui Yin Gilad Ofek Brian G Pierce | 2022/7/7 |
Immunogenicity of a germline-targeting nanoparticle in knock-in mice expressing human B cell receptors of the HIV gp41 neutralizing antibody, DH511 | The Journal of Immunology | Derek Wilson Cain Ming Tian Torben Schiffner Kimmo Rantalainen Kevin O Saunders | 2022/5/1 |
Neutralizing antibodies to hiv-1 gp41 and their use | 2022/3/31 | ||
HIV vaccine delayed boosting increases Env variable region 2–specific antibody effector functions | JCI insight | David Easterhoff Justin Pollara Kan Luo Benjamin Janus Neelakshi Gohain | 2020/1/30 |
